U-Chart Analysis:ROHTO PHARMACEUTICAL CO.,LTD.:4527

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ROHTO PHARMACEUTICAL CO.,LTD. Go to web site 4527 Medicals 東証プライム March 1, 2000 1961.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 89,210 79,951 72,791 52,964 45,307
Other Current AssetsHelp 125,549 110,295 91,515 80,107 85,399
Tangible Fixed AssetsHelp 68,607 66,182 62,839 49,790 48,539
Intangible Fixed AssetHelp 6,932 6,997 6,587 4,590 2,685
Investments and OthersHelp 53,592 43,688 38,190 35,394 31,269
Total AssetsHelp 346,175 309,677 274,876 226,149 215,644
Total Current LiabilitiesHelp 94,659 92,591 83,126 64,454 71,171
Total Long-term LiabilitiesHelp 5,190 7,516 13,350 5,787 5,190
Shareholder's EquityHelp 246,326 209,570 178,400 155,908 139,283
Total LiabilitiesHelp 346,175 309,677 274,876 226,149 215,644

ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 270,840 238,664 199,646 181,287 188,327
Total Sales 270,840 238,664 199,646 181,287 188,327
Cost of SalesHelp 113,554 101,243 83,476 74,326 74,135
Other Costs and RevenueHelp 126,348 111,043 95,042 90,218 98,783
Total CostsHelp 239,902 212,286 178,518 164,544 172,918
Net RevenueHelp 157,286 137,421 116,170 106,961 114,192
Earnings Before TaxHelp 41,518 34,290 27,874 23,006 21,730
Net IncomeHelp 30,938 26,378 21,128 16,743 15,409
Net Income 30,938 26,378 21,128 16,743 15,409

ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 34,268 30,925 27,251 20,077 19,109
Investing Cash Flow(ICF)Help -16,317 -13,176 -16,406 -10,237 -9,405
Financing Cash FlowHelp -13,784 -16,199 3,470 -2,347 -1,603
Exchange Difference of Cash and Cash EquivalentsHelp 4,703 5,236 4,335 96 -781
Net Increase and Decrease in Cash and Cash Equivalentsn 8,870 6,786 18,650 7,589 7,320

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ROHTO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

ASKA Pharmaceutical Co.,Ltd.
Medrx Co.,Ltd.
MIKASA SEIYAKU CO.,LTD.
Chiome Bioscience Inc.
TAISHO PHARMACEUTICAL CO.,LTD.
Kringle Pharma,Inc.
Shionogi & Co.,Ltd.
Sanko Junyaku Co.,Ltd.
ECI,Inc.
K Pharma,Inc.